Zevra Therapeutics (ZVRA) Shares Issued: 2015-2025
Historic Shares Issued for Zevra Therapeutics (ZVRA) over the last 4 years, with Sep 2025 value amounting to $3.0 million.
- Zevra Therapeutics' Shares Issued fell 95.25% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year decrease of 1.53%. This contributed to the annual value of $64.5 million for FY2024, which is 956.60% up from last year.
- Zevra Therapeutics' Shares Issued amounted to $3.0 million in Q3 2025, which was up 210.95% from $968,000 recorded in Q2 2025.
- Zevra Therapeutics' Shares Issued's 5-year high stood at $63.4 million during Q3 2024, with a 5-year trough of -$2.3 million in Q3 2021.
- Its 3-year average for Shares Issued is $8.5 million, with a median of $1.2 million in 2024.
- Over the last 5 years, Zevra Therapeutics' Shares Issued had its largest YoY gain of 119,466.04% in 2024, and its largest YoY loss of 142.77% in 2024.
- Over the past 5 years, Zevra Therapeutics' Shares Issued (Quarterly) stood at -$2.3 million in 2021, then reached $108,000 in 2022, then soared by 5,350.93% to $5.9 million in 2023, then soared by 119,466.04% to $63.4 million in 2024, then crashed by 95.25% to $3.0 million in 2025.
- Its Shares Issued was $3.0 million in Q3 2025, compared to $968,000 in Q2 2025 and $2.0 million in Q1 2025.